SUITEFOOD develops patented natural technologies for sugar reduction and industrial reformulation in food, beverage, nutraceuticals, oral care and pet nutrition.
01 / COMPANY & IP
Company
Suitefood S.r.l. · Innovative SME · Milan, Italy · Founded 2020 Sede operativa: Via Paolo Sarpi, 42 – 20154 Milano (MI), Italia Sede legale: Via Arnolfo di Cambio, 1/a – 20154 Milano (MI), Italia
suitefood@pec.it – REA MI – 2602663 – P.IVA IT11435250961
Intellectual property
Italian patent 102025000001257
International application PCT/EP2026/051435 Registered trademarks SUITEFOOD® and COCCOLA®
Commercial presence
ItalyFranceGermanyUnited KingdomAustriaLuxembourgSloveniaBulgariaUnited States
Industrial reformulation · Pharmacy · Amazon nutraceutical store · HoReCa and private label
02 / VISION
A future where food is held to the same research standards as medicine, and the healthier choice is the one people love.
What we believe
There are eight billion different tastes in the world.
We cannot change how the world eats.
We can change what it eats, by working with those who make it.
Sweetness is the taste every culture shares, from children to grandparents, and even our dogs.
We start there, and every validation makes the next one faster.
WHY NOW
The food industry is reformulating at a scale never seen before.
What it lacks is not demand, but technologies that deliver taste with evidence behind them.
MISSION
We develop natural taste technologies to the research standards of the pharmaceutical industry, so the companies that feed the world can make healthier food people prefer.
03 / INNOVATION JOURNAL
Innovation journal
Updates coming soon.
04 / RESTRICTED ACCESS
Documents
Documents
CONFIDENTIALRestricted access↗
CONFIDENTIAL2025 financial statements↗
CONFIDENTIALNotes to the financial statements↗
CONFIDENTIALAuditor’s report↗
05 / MILESTONES
Our journey
2020–2023
Research and development
Development of the technology behind Coccola®.
2024
Industry validation
Product tested at the headquarters of two leading Italian coffee roasters. Presented in the innovation area at SIAL Paris.
2025
Patent and market testin
Italian patent filed. Product tested in pharmacy and with end consumers.
2026
Industrialisation and scale
PCT international extension. Technology improvement and industrialisation. Commercial scale-up in Italy, Germany, France, the United Kingdom and Eastern Europe.
Next
Clinical validation
The step that turns an ingredient into an industry standard. Our next phase funds clinical validation for proprietary health claims.
06 / FINANCIAL ROUND
SUITEFOOD is raising a late seed round to fund clinical validation and scale across Europe.
Clinical validation is the step that turns an ingredient into an industry standard. European scale is what turns a standard into a market.
The round is reserved for venture capital funds and family offices.
07 / FOUNDER CONTACT
Let’s talk with the Founder
Let’s talk with the Founder Emmanuela Alesiani!
The investor deck and data room are confidential.
Write to me and I will answer personally.
Emmanuela Alesiani, Inventor & CEO
The information on this page is provided for informational purposes only. It does not constitute a public offer of financial instruments or a solicitation to invest. Projections contained in confidential materials are estimates and do not guarantee future results.